stay updated with our newsletter

Search
Close this search box.

Blocking Galectin-3 with Modified Citrus Pectin Supports Cognition and May Help Prevent Alzheimer’s

Cognitive impairment and the development of Alzheimer’s disease are recognized risk factors in type 2 diabetes mellitus. Research continues to link metabolic dysregulation and specifically, insulin resistance, with Alzheimer’s disease and other forms of cognitive loss.   Galectin-3 Fuels Diabetes and Cognitive Decline Emerging research into the beta-galactoside binding protein Galectin-3 (Gal-3) offersRead

Addressing Dyslipidemia Using Personalized Medicine

In this episode of the OneMedicine Podcast, featuring Dr Mark Houston, we discuss dyslipidemia including common misconceptions, suggested testing, and an overview of the highly personalized approach he recommends for successful outcomes. “Precision and personalized cardiovascular medicine must be the new medicine of today and the future,” says Mark Houston,Read

Natural Neurology

Our podcast, featuring Karta Purkh (“KP”) Singh Khalsa, AD, a Dietitian-Nutritionist and Ayurveda expert, international lecturer and author of 31 books on natural healing topics, is a must-listen for anyone interested in a natural approach to neurology. Khalsa will share easy-to-apply clinical approaches that empower patients and professionals and toRead

Is Your Clinical Approach to SIBO Treatment Leading to Recurrence? (Podcast)

Why is SIBO (small intestinal bowel overgrowth) challenging to treat? Might the issue lie in hasty diagnoses and repetitive treatments without deeply exploring the root cause of SIBO? Could its persistent nature be attributed to the common approach of using antibiotics or herbal equivalents and restrictive diets aimed at starving gut bacteria? Join us today for an honest discussion with Angela Pifer, the renowned SIBO Guru

Study Finds Biomarkers That Identify Long COVID With 96 Percent Accuracy

A study published in Nature on Sept 18 (Accelerated Article Preview) and reported in Medscape, has found biomarkers that identify long COVID with 96 percent accuracy based on distinctive features in blood samples. The cross-sectional research involved 273 individuals with or without long COVID. These findings are critically important since the CDC reportsRead

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.